Clinical trial
Prospective Comparative Study of the Efficacy of Acupuncture Versus Conventional Treatment for the Management of Chronic Pain in Patients With Chronic Kidney Disease Receiving Conservative Treatment or Renal Replacement Therapy (Peritoneal Dialysis or Hemodialysis)
NCT07891819 is registered in ClinicalTrials.gov with Federal University of São Paulo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Comparative Study of the Efficacy of Acupuncture Versus Conventional Treatment for the Management of Chronic Pain in Patients With Chronic Kidney Disease Receiving Conservative Treatment or Renal Replacement Therapy (Peritoneal Dialysis or Hemodialysis)
- Lead sponsor
- Federal University of São Paulo
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 6, 2023
- Completion date
- February 17, 2026
- Enrollment
- 110 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic pain, neuralgia, renal insufficiency,chronic
Arms
As registered; 2 arms.
-
Acupuncture plus conventional treatment - Experimental
Individualized acupuncture administered weekly for approximately four months, with 16 sessions planned and a minimum of 10 sessions considered necessary for efficacy evaluation. Participants also received optimized conventional pharmacological treatment.
-
Conventional treatment alone
Optimized conventional pharmacological treatment for chronic pain, without acupuncture.
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Change in pain intensity from baseline to the final study visit
Change in pain intensity from baseline to 5 months, measured using the 0-to-10 Visual Analog Scale (VAS) for pain, where 0 indicates no pain and 10 the worst imaginable pain. Higher scores indicate worse pain; a negative change indicates improvement.
Lead sponsor's other trials
Federal University of São Paulo, most recent start first.
+433 more trials
Similar trials
Same condition (Neuralgia) and phase, most recent start first.
+377 more trials See the condition page